NEO-MEDROL ACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Neo-medrol Acetate, and what generic alternatives are available?
Neo-medrol Acetate is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in NEO-MEDROL ACETATE is methylprednisolone acetate; neomycin sulfate. There are forty drug master file entries for this compound. Additional details are available on the methylprednisolone acetate; neomycin sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEO-MEDROL ACETATE?
- What are the global sales for NEO-MEDROL ACETATE?
- What is Average Wholesale Price for NEO-MEDROL ACETATE?
Summary for NEO-MEDROL ACETATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 2 |
DailyMed Link: | NEO-MEDROL ACETATE at DailyMed |
Recent Clinical Trials for NEO-MEDROL ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fayoum University Hospital | Phase 4 |
Mercy Health Ohio | Phase 4 |
US Patents and Regulatory Information for NEO-MEDROL ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | NEO-MEDROL ACETATE | methylprednisolone acetate; neomycin sulfate | CREAM;TOPICAL | 060611-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmacia And Upjohn | NEO-MEDROL ACETATE | methylprednisolone acetate; neomycin sulfate | CREAM;TOPICAL | 060611-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |